Abstract:Background: Transgender women (hereafter "trans women") face social marginalization, stigma, and discrimination and experience a high burden of HIV. More recently, trans women have been identified as having a high risk for hepatitis C (HCV) infection. The interaction between these two diseases and the risks for HIV/HCV co-infection among trans women are understudied. Objective: To characterize epidemiological, behavioral, and socio-structural interactions between HIV and HCV infections among trans women. Methods: This cross-sectional study examined data from a community-based survey of trans women in San Francisco recruited through respondent-driven sampling (RDS) in 2019/2020. Face-to-face interviews collected data on demographics, medical history, drug injection practices, sexual behavior, and socio-structural factors (e.g., poverty, housing insecurity, incarceration, social support). HIV and HCV antibodies were detected using oral fluid rapid tests and prior diagnosis and treatment were collected by self-report. Blood specimens were collected to confirm antibodies using ELISA. Multinomial logistic regression analysis characterized factors associated with HIV infection alone, HCV infection alone, and HIV/HCV co-infection compared to neither infection. Results: Among 201 trans women recruited, HIV prevalence was 42.3%; HCV infection by history or current seroprevalence was 28.9%; evidence for both HIV and HCV infection was present for 18.9%. Two-thirds of trans women (67.2%) had been incarcerated; 30.8% had ever injected drugs. History of injection drug use and receiving emotional support from family were factors found in common for HIV infection, HCV infection, and HIV/HCV co-infection compared to no infection. Having a sexual partner who injects drugs was associated with HIV infection alone. Not lacking care due to cost and older age were associated with co-infection. Older age was also associated with HCV infection. Of trans women with HIV infection, 91.8% had accessed HIV care, whereas only 62% with HCV had accessed some form of care. Conclusions: Our study found high levels of HIV, HCV, and HIV/HCV co-infection among trans women in San Francisco. We found common associations between HIV and HCV through injection practices and emotional support, but having a sexual partner who injects drugs was not associated with HCV infection alone or co-infection. We note a substantial gap in the treatment of HCV for trans women, including those in HIV care, that needs to be urgently addressed.

New insights into the progression of aortic stenosis: implications for secondary prevention.

Preliminary Research on the Co-Infection of Human Immunodeficiency Virus and Hepatitis Virus in Intravenous Drug Users

Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Romania, 2020 to 2023

Hepatitis B Prevalence and Referral Rates in Vulnerable Populations Undergoing Community-Based Screening—Results from the LIVE(RO)2 Program

Estimating the Current Routes of Transmission in HIV-1 F1 Subtype Infected Persons in Romania: Differences in Self-Reporting and Phylogenetic Data

Prevalence of hepatitis B and C in HIV-infected patients: a meta-analysis.

Stigma‐associated attitudes and practices among Romanian clinical providers

Prevalence Of Hiv, Syphilis, Hcv And Their High Risk Behaviors Among Migrant Workers In Eastern China

[Survey of Prevalence of HIV Infection, Syphilis and HCV Infection and Related Risk Behaviors among Club Drug Users in Zhejiang, 2011].

Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review

[Incidence Rate of HIV Transmission in HIV Discordant Couples in Zhejiang Province, 2009-2013].

HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020

Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia

Eliminating HCV infection from prisons in sicily: the SINTESI project

Coinfection With Hiv And Hepatitis C Virus Among Injection Drug Users In Southern China

Chronic Hepatitis C Cascade of Care in Prisoners—Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy

Hepatitis B, hepatitis C and HIV co-infection at an antiretroviral centre in Delhi

HBV and HCV Co-Infection in Chinese Newly Diagnosed HIV+ Subjects in 2015 and 2023: A Cross-Sectional Study

High Prevalence and Genetic Diversity of HCV among HIV-1 Infected People from Various High-Risk Groups in China

Cross-Sectional Study to Determine the Prevalence of Hepatitis B and C Virus Infection in High Risk Groups in the Northeast Region of Brazil